Asia Pacific Respiratory Inhalers Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type [Nebulizers, Metered Dose Inhalers (MDI), and Dry Powder Inhalers], Technology (Manually Operated Inhalers and Digitally Operated Inhalers), and Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, and Others)
The Asia Pacific respiratory inhalers market is expected to grow from US$ 6,397.09 million in 2022 to US$ 9,297.48 million by 2028. It is estimated to register a CAGR of 6.4% from 2022 to 2028.
Increasing Product Development Activities to Fuel Asia Pacific Respiratory Inhalers Market Growth
With new medical knowledge and effective medicines, treatment with a wide range of asthma inhalers continues to advance. Rising use of ventilator combination therapies and increasing investments by major players in developing sophisticated ventilator inhalers are boosting the demand for respiratory inhalers. In addition to the numerous advantages of the device, such as portability, convenience, and effectiveness, the growing number of product approvals and developments is expected to strengthen the demand for respiratory inhalers in the coming years. A few of the major developments and approvals have taken place in recent years. For instance, in November 2022, AstraZeneca partnered with Avillion to develop PT027, an asthma rescue inhaler. PT027 is a pressurized metered-dose inhaler that delivers a fixed dose of two combined asthma medications: albuterol—a short-acting beta2-agonist and budesonide, an anti-inflammatory inhaled corticosteroid. Similarly, in December 2020, OMRON launched WheezeScan, the world’s first wheeze detection device to help children with asthma, which is a crucial breakthrough in the field of pediatric asthma management. WheezeScan helps parents of young children detect wheezing—a clear indicator of an upcoming asthma attack-—and act accordingly. Thus, such increasing advancements by various market players and product approvals are likely to catalyze the growth of the Asia Pacific respiratory inhalers market during the forecast period.
Asia Pacific Respiratory Inhalers Market Overview
The market for Asia Pacific includes Japan, China, India, South Korea, Australia, and the Rest of APAC. Asia Pacific is expected to be the fastest-growing region, with China accounting for the major market share. China is one of the fastest developing economies in Asia Pacific, with a GDP of US$ 18 trillion, which accounts for 18% of the global economy. Healthcare expenditure in the country accounts for 7.1% of the GDP. As per China Macro Economy Journal 2021, ~264 million people aged 60 years and above accounted for 18.7% of the total population of the country. The presence of a large geriatric population has increased the respiratory disease burden as the elderly population is prone to various health conditions. As per the Frontier Media Public Health report published in June 2022, the most recent Chinese national survey of COPD showed that China accounted for almost 25% of all COPD cases globally. Compared to the survey results from 10 years ago, the prevalence of COPD has increased by 67% in the 40 and older group and has reached epidemic proportions. Moreover, asthma is a major public health challenge in the country, affecting millions of people. According to the National Library of Medicine, the prevalence of asthma in 2019 was 4.2%, representing 45.7 million people in the country. This has further increased the demand for respiratory inhalers. Moreover, the COVID-19 outbreak created a demand for respiratory inhalers. The geographical expansion of various companies from other countries is also likely to support the market growth.
Asia Pacific Respiratory Inhalers Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Respiratory Inhalers Market Segmentation
The Asia Pacific respiratory inhalers market is segmented based on product type, technology, disease indication, and country.
Based on product type, the Asia Pacific respiratory inhalers market is segmented into nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment held the largest share of the Asia Pacific respiratory inhalers market in 2022.
Based on technology, the Asia Pacific respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger share of the Asia Pacific respiratory inhalers market in 2022.
Based on disease indication, the Asia Pacific respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the Asia Pacific respiratory inhalers market in 2022.
Based on country, the Asia Pacific respiratory inhalers market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific respiratory inhalers market in 2022.
AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd; GSK Plc; Koninklijke Philips NV; OMRON Corp; OPKO Health, Inc; PARI Respiratory Equipment, Inc.; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the Asia Pacific respiratory inhalers market.
Increasing Product Development Activities to Fuel Asia Pacific Respiratory Inhalers Market Growth
With new medical knowledge and effective medicines, treatment with a wide range of asthma inhalers continues to advance. Rising use of ventilator combination therapies and increasing investments by major players in developing sophisticated ventilator inhalers are boosting the demand for respiratory inhalers. In addition to the numerous advantages of the device, such as portability, convenience, and effectiveness, the growing number of product approvals and developments is expected to strengthen the demand for respiratory inhalers in the coming years. A few of the major developments and approvals have taken place in recent years. For instance, in November 2022, AstraZeneca partnered with Avillion to develop PT027, an asthma rescue inhaler. PT027 is a pressurized metered-dose inhaler that delivers a fixed dose of two combined asthma medications: albuterol—a short-acting beta2-agonist and budesonide, an anti-inflammatory inhaled corticosteroid. Similarly, in December 2020, OMRON launched WheezeScan, the world’s first wheeze detection device to help children with asthma, which is a crucial breakthrough in the field of pediatric asthma management. WheezeScan helps parents of young children detect wheezing—a clear indicator of an upcoming asthma attack-—and act accordingly. Thus, such increasing advancements by various market players and product approvals are likely to catalyze the growth of the Asia Pacific respiratory inhalers market during the forecast period.
Asia Pacific Respiratory Inhalers Market Overview
The market for Asia Pacific includes Japan, China, India, South Korea, Australia, and the Rest of APAC. Asia Pacific is expected to be the fastest-growing region, with China accounting for the major market share. China is one of the fastest developing economies in Asia Pacific, with a GDP of US$ 18 trillion, which accounts for 18% of the global economy. Healthcare expenditure in the country accounts for 7.1% of the GDP. As per China Macro Economy Journal 2021, ~264 million people aged 60 years and above accounted for 18.7% of the total population of the country. The presence of a large geriatric population has increased the respiratory disease burden as the elderly population is prone to various health conditions. As per the Frontier Media Public Health report published in June 2022, the most recent Chinese national survey of COPD showed that China accounted for almost 25% of all COPD cases globally. Compared to the survey results from 10 years ago, the prevalence of COPD has increased by 67% in the 40 and older group and has reached epidemic proportions. Moreover, asthma is a major public health challenge in the country, affecting millions of people. According to the National Library of Medicine, the prevalence of asthma in 2019 was 4.2%, representing 45.7 million people in the country. This has further increased the demand for respiratory inhalers. Moreover, the COVID-19 outbreak created a demand for respiratory inhalers. The geographical expansion of various companies from other countries is also likely to support the market growth.
Asia Pacific Respiratory Inhalers Market Revenue and Forecast to 2028 (US$ Million)
Asia Pacific Respiratory Inhalers Market Segmentation
The Asia Pacific respiratory inhalers market is segmented based on product type, technology, disease indication, and country.
Based on product type, the Asia Pacific respiratory inhalers market is segmented into nebulizers, metered dose inhalers (MDI), and dry powder inhalers. The dry powder inhalers segment held the largest share of the Asia Pacific respiratory inhalers market in 2022.
Based on technology, the Asia Pacific respiratory inhalers market is bifurcated into manually operated inhalers and digitally operated inhalers. The manually operated inhalers segment held a larger share of the Asia Pacific respiratory inhalers market in 2022.
Based on disease indication, the Asia Pacific respiratory inhalers market is segmented into asthma, COPD, pulmonary arterial hypertension, and others. The asthma segment held the largest share of the Asia Pacific respiratory inhalers market in 2022.
Based on country, the Asia Pacific respiratory inhalers market has been categorized into China, India, Japan, South Korea, Australia, and the Rest of Asia Pacific. China dominated the Asia Pacific respiratory inhalers market in 2022.
AstraZeneca Plc; Beximco Pharmaceuticals Ltd.; Boehringer Ingelheim International GmbH; Cipla Ltd; GSK Plc; Koninklijke Philips NV; OMRON Corp; OPKO Health, Inc; PARI Respiratory Equipment, Inc.; and Teva Pharmaceutical Industries Ltd are the leading companies operating in the Asia Pacific respiratory inhalers market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Respiratory Inhalers Market – by Product Type
1.3.2 Asia Pacific Respiratory Inhalers Market – by Technology
1.3.3 Asia Pacific Respiratory Inhalers Market – by Disease Indication
1.3.4 Asia Pacific Respiratory Inhalers Market – by Country
2. ASIA PACIFIC RESPIRATORY INHALERS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC RESPIRATORY INHALERS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert’s Opinion
5. ASIA PACIFIC RESPIRATORY INHALERS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Cases of Respiratory Disorders
5.1.2 Growing Adoption of Generic Inhalers
5.2 Market Restraints
5.2.1 Lack of Early Diagnosis and High Cost of Inhalers
5.3 Market Opportunities
5.3.1 Increasing Adoption of Smart Inhalers Technology
5.4 Future Trends
5.4.1 Increasing Product Development Activities
5.5 Impact Analysis
6. RESPIRATORY INHALERS MARKET – ASIA PACIFIC ANALYSIS
6.1 Asia Pacific Respiratory Inhalers Market Revenue Forecast and Analysis
7. ASIA PACIFIC RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – BY PRODUCT TYPE
7.1 Overview
7.2 Asia Pacific Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Dry Powder Inhalers
7.3.1 Overview
7.3.2 Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Multi-Dose Dry Powder Inhalers
7.3.3.1 Overview
7.3.3.2 Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Single Dose Dry Powder Inhalers
7.3.4.1 Overview
7.3.4.2 Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metered Dose Inhalers
7.4.1 Overview
7.4.2 Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Pressured Metered Dose Inhalers
7.4.3.1 Overview
7.4.3.2 Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Connected Metered Dose Inhalers
7.4.4.1 Overview
7.4.4.2 Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Nebulizers
7.5.1 Overview
7.5.2 Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Compressed Air Nebulizers
7.5.3.1 Overview
7.5.3.2 Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Mesh Air Nebulizers
7.5.4.1 Overview
7.5.4.2 Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Ultrasonic Air Nebulizers
7.5.5.1 Overview
7.5.5.2 Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8. ASIA PACIFIC RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY TECHNOLOGY
8.1 Overview
8.2 Asia Pacific Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
8.3 Manually Operated Inhalers
8.3.1 Overview
8.3.2 Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Digitally Operated Inhalers
8.4.1 Overview
8.4.2 Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9. ASIA PACIFIC RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY DISEASE INDICATION
9.1 Overview
9.2 Asia Pacific Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
9.3 Asthma
9.3.1 Overview
9.3.2 Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 COPD
9.4.1 Overview
9.4.2 COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pulmonary Arterial Hypertension
9.5.1 Overview
9.5.2 Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10. ASIA PACIFIC RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 Asia Pacific: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.1.1.1 China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 China: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.1.3.1 China: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.1.3.2 China: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.1.3.3 China: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.1.4 China: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.1.5 China Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.2 Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Japan: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.2.3.1 Japan: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.2.3.2 Japan: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.2.3.3 Japan: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.2.4 Japan: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.2.5 Japan: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.3 India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.3.3.1 India: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.3.3.2 India: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.3.3.3 India: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.3.4 India: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.3.5 India: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.4 Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Australia: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.4.3.1 Australia: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.4.3.2 Australia: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.4.3.3 Australia: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.4.4 Australia: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.4.5 Australia: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.5 South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 South Korea: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.5.3.1 South Korea: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.5.3.2 South Korea: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.5.3.3 South Korea: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.5.4 South Korea: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.5.5 South Korea: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.6.3.1 Rest of Asia Pacific: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.6.3.2 Rest of Asia Pacific: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.6.3.3 Rest of Asia Pacific: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. COMPANY PROFILES
12.1 AstraZeneca Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Beximco Pharmaceuticals Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boehringer Ingelheim International GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cipla Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GSK Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 OMRON Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PARI Respiratory Equipment, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 OPKO Health, Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Respiratory Inhalers Market – by Product Type
1.3.2 Asia Pacific Respiratory Inhalers Market – by Technology
1.3.3 Asia Pacific Respiratory Inhalers Market – by Disease Indication
1.3.4 Asia Pacific Respiratory Inhalers Market – by Country
2. ASIA PACIFIC RESPIRATORY INHALERS MARKET – KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. ASIA PACIFIC RESPIRATORY INHALERS MARKET – MARKET LANDSCAPE
4.1 Overview
4.2 Asia Pacific PEST Analysis
4.3 Expert’s Opinion
5. ASIA PACIFIC RESPIRATORY INHALERS MARKET – KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Rising Cases of Respiratory Disorders
5.1.2 Growing Adoption of Generic Inhalers
5.2 Market Restraints
5.2.1 Lack of Early Diagnosis and High Cost of Inhalers
5.3 Market Opportunities
5.3.1 Increasing Adoption of Smart Inhalers Technology
5.4 Future Trends
5.4.1 Increasing Product Development Activities
5.5 Impact Analysis
6. RESPIRATORY INHALERS MARKET – ASIA PACIFIC ANALYSIS
6.1 Asia Pacific Respiratory Inhalers Market Revenue Forecast and Analysis
7. ASIA PACIFIC RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – BY PRODUCT TYPE
7.1 Overview
7.2 Asia Pacific Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
7.3 Dry Powder Inhalers
7.3.1 Overview
7.3.2 Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Multi-Dose Dry Powder Inhalers
7.3.3.1 Overview
7.3.3.2 Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Single Dose Dry Powder Inhalers
7.3.4.1 Overview
7.3.4.2 Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Metered Dose Inhalers
7.4.1 Overview
7.4.2 Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Pressured Metered Dose Inhalers
7.4.3.1 Overview
7.4.3.2 Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Connected Metered Dose Inhalers
7.4.4.1 Overview
7.4.4.2 Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Nebulizers
7.5.1 Overview
7.5.2 Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Compressed Air Nebulizers
7.5.3.1 Overview
7.5.3.2 Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Mesh Air Nebulizers
7.5.4.1 Overview
7.5.4.2 Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Ultrasonic Air Nebulizers
7.5.5.1 Overview
7.5.5.2 Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8. ASIA PACIFIC RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY TECHNOLOGY
8.1 Overview
8.2 Asia Pacific Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
8.3 Manually Operated Inhalers
8.3.1 Overview
8.3.2 Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Digitally Operated Inhalers
8.4.1 Overview
8.4.2 Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9. ASIA PACIFIC RESPIRATORY INHALERS MARKET ANALYSIS AND FORECAST TO 2028 – BY DISEASE INDICATION
9.1 Overview
9.2 Asia Pacific Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
9.3 Asthma
9.3.1 Overview
9.3.2 Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 COPD
9.4.1 Overview
9.4.2 COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Pulmonary Arterial Hypertension
9.5.1 Overview
9.5.2 Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10. ASIA PACIFIC RESPIRATORY INHALERS MARKET – REVENUE AND FORECAST TO 2028 – COUNTRY ANALYSIS
10.1 Overview
10.1.1 Asia Pacific: Respiratory Inhalers Market, by Country, 2021 & 2028 (%)
10.1.1.1 China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 China: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.1.3.1 China: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.1.3.2 China: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.1.3.3 China: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.1.4 China: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.1.5 China Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.2 Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Japan: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.2.3.1 Japan: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.2.3.2 Japan: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.2.3.3 Japan: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.2.4 Japan: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.2.5 Japan: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.3 India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 India: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.3.3.1 India: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.3.3.2 India: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.3.3.3 India: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.3.4 India: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.3.5 India: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.4 Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.4.3 Australia: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.4.3.1 Australia: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.4.3.2 Australia: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.4.3.3 Australia: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.4.4 Australia: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.4.5 Australia: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.5 South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.5.3 South Korea: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.5.3.1 South Korea: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.5.3.2 South Korea: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.5.3.3 South Korea: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.5.4 South Korea: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.5.5 South Korea: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
10.1.1.6 Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Respiratory Inhalers Market, by Product Type, 2019–2028 (US$ Million)
10.1.1.6.3.1 Rest of Asia Pacific: Respiratory Inhalers Market, by Dry Powder Inhalers, 2019–2028 (US$ Million)
10.1.1.6.3.2 Rest of Asia Pacific: Respiratory Inhalers Market, by Metered Dose Inhalers (MDI), 2019–2028 (US$ Million)
10.1.1.6.3.3 Rest of Asia Pacific: Respiratory Inhalers Market, by Nebulizers, 2019–2028 (US$ Million)
10.1.1.6.4 Rest of Asia Pacific: Respiratory Inhalers Market, by Technology, 2019–2028 (US$ Million)
10.1.1.6.5 Rest of Asia Pacific: Respiratory Inhalers Market, by Disease Indication, 2019–2028 (US$ Million)
11. INDUSTRY LANDSCAPE
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. COMPANY PROFILES
12.1 AstraZeneca Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Beximco Pharmaceuticals Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boehringer Ingelheim International GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cipla Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 GSK Plc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Koninklijke Philips NV
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 OMRON Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 PARI Respiratory Equipment, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 OPKO Health, Inc
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. China Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. China Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 3. China Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 4. China Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 5. China Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 6. China Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 10. Japan Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 11. Japan Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 12. Japan Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 13. India Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. India Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 15. India Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 16. India Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 17. India Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 18. India Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Australia Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Australia Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 21. Australia Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 22. Australia Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 23. Australia Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 24. Australia Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 25. South Korea Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. South Korea Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 27. South Korea Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 28. South Korea Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 29. South Korea Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 30. South Korea Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Asia Pacific Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Asia Pacific Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Asia Pacific Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of Asia Pacific Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Asia Pacific Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Asia Pacific Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 37. Recent Inorganic Growth Strategies
Table 38. Recent Organic Growth Strategies
Table 39. Glossary of Terms
Table 1. China Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 2. China Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 3. China Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 4. China Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 5. China Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 6. China Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 7. Japan Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 10. Japan Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 11. Japan Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 12. Japan Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 13. India Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 14. India Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 15. India Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 16. India Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 17. India Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 18. India Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 19. Australia Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 20. Australia Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 21. Australia Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 22. Australia Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 23. Australia Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 24. Australia Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 25. South Korea Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 26. South Korea Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 27. South Korea Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 28. South Korea Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 29. South Korea Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 30. South Korea Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 31. Rest of Asia Pacific Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 32. Rest of Asia Pacific Respiratory Inhalers Market, by Dry Powder Inhalers– Revenue and Forecast to 2028 (US$ Million)
Table 33. Rest of Asia Pacific Respiratory Inhalers Market, by Metered Dose Inhalers (MDI)– Revenue and Forecast to 2028 (US$ Million)
Table 34. Rest of Asia Pacific Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)
Table 35. Rest of Asia Pacific Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)
Table 36. Rest of Asia Pacific Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)
Table 37. Recent Inorganic Growth Strategies
Table 38. Recent Organic Growth Strategies
Table 39. Glossary of Terms
LIST OF FIGURES
Figure 1. Asia Pacific Respiratory Inhalers Market Segmentation
Figure 2. Asia Pacific Respiratory Inhalers Market, by Country
Figure 3. Asia Pacific Respiratory Inhalers Market Overview
Figure 4. Asia Pacific Respiratory Inhalers Market, By Product
Figure 5. Asia Pacific Respiratory Inhalers Market, By Country
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Asia Pacific Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Respiratory Inhalers Market – Revenue Forecast and Analysis
Figure 10. Asia Pacific Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 11. Dry Powder Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Multi-Dose Dry Powder Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Single Dose Dry Powder Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Metered Dose Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Pressured Metered Dose Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Connected Metered Dose Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Nebulizers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Compressed Air Nebulizers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Mesh Air Nebulizers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ultrasonic Air Nebulizers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Asia Pacific Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
Figure 22. Manually Operated Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Digitally Operated Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Asia Pacific Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
Figure 25. Asthma: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. COPD: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Pulmonary Arterial Hypertension: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Asia Pacific: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 30. China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 1. Asia Pacific Respiratory Inhalers Market Segmentation
Figure 2. Asia Pacific Respiratory Inhalers Market, by Country
Figure 3. Asia Pacific Respiratory Inhalers Market Overview
Figure 4. Asia Pacific Respiratory Inhalers Market, By Product
Figure 5. Asia Pacific Respiratory Inhalers Market, By Country
Figure 6. Asia Pacific: PEST Analysis
Figure 7. Experts’ Opinion
Figure 8. Asia Pacific Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific Respiratory Inhalers Market – Revenue Forecast and Analysis
Figure 10. Asia Pacific Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)
Figure 11. Dry Powder Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Multi-Dose Dry Powder Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Single Dose Dry Powder Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Metered Dose Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Pressured Metered Dose Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Connected Metered Dose Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Nebulizers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Compressed Air Nebulizers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Mesh Air Nebulizers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ultrasonic Air Nebulizers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Asia Pacific Respiratory Inhalers Market, by Technology 2021 & 2028 (%)
Figure 22. Manually Operated Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Digitally Operated Inhalers: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Asia Pacific Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)
Figure 25. Asthma: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. COPD: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Pulmonary Arterial Hypertension: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Asia Pacific Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Asia Pacific: Respiratory Inhalers Market, by Key Country – Revenue (2021) (US$ Million)
Figure 30. China: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31. Japan: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. India: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Australia: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. South Korea: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. Rest of Asia Pacific: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)
